Physician profile
Vijay Thumma
NPI 1982895827
$659.15
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.25 · 2020: $120 · 2021: $130 · 2022: $82.23 · 2023: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $255.62 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $202.11 | 2019-2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.74 | 2023 | Xifaxan |
| Paratek Pharmaceuticals, INC. | $39.71 | 2022-2023 | Nuzyra |
| Vifor Pharma, INC. | $23.39 | 2021 | |
| Inari Medical, INC. | $19.10 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Baxter Healthcare | $18.88 | 2023 | Hillrom - Life 2000 Ventilation System |
| Boston Scientific Corporation | $13.54 | 2023 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.49 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Thumma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.